Vulcan Biologics provides a biotechnology platform that offers stable and persistent modulation of microbiomes.
Vulcan Biologics has raised $990K in total funding. The most recent round was Grant. The last funding was announced in December 2021.
Vulcan Biologics's investors include National Science Foundation.
Vulcan Biologics is headquartered in Irvine, United States.
Vulcan Biologics provides a biotechnology platform that offers stable and persistent modulation of microbiomes.
Vulcan Biologics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vulcan Biologics — Funding & Investors." VCBacked, December 8, 2021, https://www.vcbacked.co/company/vulcan-biologics. Accessed September 30, 2026.
VCBacked. (2021). Vulcan Biologics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/vulcan-biologics
{{cite web |title=Vulcan Biologics — Funding & Investors |url=https://www.vcbacked.co/company/vulcan-biologics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated